-
Mashup Score: 8Addition of an immune checkpoint inhibitor reduces the risk of disease progression for select patients with anal cancer - 14 hour(s) ago
Click on the article title to read more.
Categories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 17Colorectal cancer screening and prevention - 2 month(s) ago
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. This issue addresses efforts to optimize colonoscopy measures and broa…
Categories: General Medicine News, Oncologists1Tweet-
Featured now in #CancerScope! Optimizing colonoscopy measures & expanding screening access are critical to reducing disparities in colorectal cancer prevention. Read more: https://t.co/wkV5uEQ1ll @AmCollegeGastro @ASGEendoscopy @IUMedSchool @AmericanCancer @Color @OncoAlert https://t.co/hv3nxo18xX
-
-
Mashup Score: 5First person profile: Patrick J. Loehrer, MD - 12 month(s) ago
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, Patrick J. Loehrer, MD, has had a lifelong passion for …
Categories: General Medicine News, Onc News and JournalsTweet-
New first person profile: Patrick J. Loehrer, MD (@IU_Health) Dr Loehrer’s lifelong passion for bringing high-quality oncology care to underresourced communities has taken on global dimensions. https://t.co/qFnmoW2Rbt #CancerScope @OncoAlert https://t.co/EH6a6Vzujd
-
-
Mashup Score: 2Oral health linked to survival in head and neck cancer - 12 month(s) ago
Click on the article title to read more.
Categories: General Medicine News, Onc News and JournalsTweet-
New in #CancerScope | Good oral health, specifically retaining natural teeth and frequently visiting the dentist, in patients with head and neck squamous cell carcinoma appears to be associated with improved overall survival. https://t.co/F8ttn3Rcqk https://t.co/VIpYDmqXsq
-
-
Mashup Score: 6Discrepancy in accelerated approvals for cancer drugs in the United States and Europe - 1 year(s) ago
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, the discrepancy in accelerated approvals for cancer dru…
Categories: General Medicine News, Onc News and JournalsTweet-
New #CancerScope | The FDA and the EMA have different lists of drugs for which accelerated approvals have been withdrawn, and patient confusion can be a result. https://t.co/zmw3hLqvwy @OncoAlert https://t.co/zGAdlbuwjk
-
-
Mashup Score: 0First person profile: Jedd Wolchok, MD - 1 year(s) ago
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, Jedd Wolchok, MD, was on the front lines of investigati…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New #CancerScope first person profile: Jedd Wolchok, MD Dr Wolchok was on the front lines of investigating immunotherapy science and developed the first immunologic agents to treat #melanoma https://t.co/UdVxckbpoB https://t.co/uIXpDrFxO4
-
-
Mashup Score: 0Trastuzumab deruxtecan shows durable activity in HER2‐mutant non–small cell lung cancer - 3 year(s) ago
Click on the article title to read more.
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A recent study shows that the HER2-targeted antibody drug conjugate trastuzumab deruxtecan (T-DXd) produced durable anticancer activity in pats w/ metastatic HER2-mutant NSCLC that was refractory to standard treatment. Our latest #CancerScope shares more: https://t.co/91sM5Uyl00
-
-
Mashup Score: 0Gut microbiome linked to aggressive prostate cancer - 3 year(s) ago
Click on the article title to read more.
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers at @ClevelandClinic have demonstrated that diet-associated molecules in the gut are associated with aggressive #ProstateCancer. Our latest #CancerScope examines the study's findings: https://t.co/GUhxcBpAAX
-
-
Mashup Score: 0Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma - 3 year(s) ago
Click on the article title to read more.
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New research has demonstrated a link between the presence of cutaneous β human papillomavirus (β-HPV) and the risk of cutaneous squamous cell carcinoma (cuSCC). Our February 15 #CancerScope covers the findings: https://t.co/VH1E7lFUyq
-
-
Mashup Score: 1First Person Profile: Smita Bhatia, MD, MPH - 3 year(s) ago
Click on the article title to read more.
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Recognized as a thought leader in the fields of #PediatricOncology, #Survivorship, and outcomes, Smita Bhatia, MD, MPH (@ONealCancerUAB) is well-known as a fully invested mentor and extraordinary role model. Our latest edition of #CancerScope shares more: https://t.co/8fUnOYQfRA https://t.co/GbWGyNlalR
-
Now in #CancerScope | Recent work from Rao et al. found immune checkpoint inhibitor retifanlimab improved upon standard chemotherapy among select patients with anal cancer. CANCER Section Editor @CathyEngMD also weighs in: https://t.co/53WTcRMFKa @OncoAlert @Annals_Oncology https://t.co/n2nnoXja53